Molecule intelOpportunity: Moderate0Crowded market

Diclofenac

609 brands · 293 companies · product forms

5 DRAP alerts

Opportunity snapshot

Launch attractiveness
37
Market saturation
100
Price room
100
Regulatory risk
90
609
brands
293
companies
Rs 181.2
median price
70
price points
102.31x
price spread
90
confidence %

Who competes here

Top companies by brand count — fragmented market (no dominant player) · leader share 1%

Price room

Across observed sources and strengths
CheapestRs 46.65
MedianRs 181.2
Most expensiveRs 4,772.7
Spread102.31×
Sources: DRAP-official, DVAGO, Servaid

max/min price ratio 102.31x across 70 trusted points (Rs 46.65-4772.7). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Brands & products on the market

Sample of 12 live products for Diclofenac — each links to its own medicine page.

Regulatory alerts

Recall exposurelatest 2026-01-14
Drug Safety Alert: Risk of Anaphylactic Reaction / Anaphylactic Shock with Diclofenac Sodi
Suspension of Drug Registration: Tablets of Diclofenac Potassium in Strengths of 75mg and
Recall Alert: Drug Product; Fentos 50mg Tablets (Batch # 599) By M/s. Hisun Pharmaceutical
Recall Alert: Drug Product; Fenbar 50mg Tablets (Batch # 2752) by M/s Usawa Pharmaceutical
129. Recall Alert(Class-I) – DIFAM Injection 3ml (Bosch Pharma) – Substandard

Why this score

Launch attractiveness

40% supply-gap(20) + 25% price-variation(100) + 20% low-competition(0) + 15% supply-disruption(40), damped by confidence(90). Higher = more attractive, less crowded opportunity.

Market saturation

293 canonical companies and 609 brands compete (saturation pegged at 30 companies / 150 brands).

Price room

max/min price ratio 102.31x across 70 trusted points (Rs 46.65-4772.7). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Regulatory risk

5 DRAP alert(s), latest 2026-01-14 incl. recall/safety.

Confidence

Reduced by: no ATC code.

Packaged brief for this moderate opportunity?

Molecule page + company profiles + price-room analysis are the pilot package for pharma teams.

See packaged reports All 3868 molecules

Molecule intelligence as of 2026-07-30. Brand/company counts from DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.